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Pancreatic tumors are uncommon in children and rarely result in biliary obstruction. A previously well
12-year old female presented with a one-week history of fatigue, pruritis, and painless jaundice.
Abdominal ultrasound demonstrated a mass in the pancreatic head associated with dilation of the
common bile duct. Further workup included abdominal MRI, CT and endoscopic retrograde pancreaticogram (ERCP) with biliary stenting. Octreotide scan did not reveal uptake in the pancreatic tumor.
Percutaneous biopsies were consistent with a grade 2 pancreatic neuroendocrine tumor (NET). Preoperative imaging demonstrated involvement of the portal vein. The patient was brought the operating
room for a pancreaticoduodenectomy and portal vein resection. Final pathology revealed a T3N1M0
pancreatic NET. The patient recovered uneventfully.
Ó 2014 The Authors. Published by Elsevier Inc. All rights reserved.
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Pancreatic tumors are exceedingly rare in children and adolescents. Neuroendocrine tumors (NET) account for approximately
25% of pediatric pancreatic masses [1,2]. NET arise from endocrine
tissues of the pancreas and are classiﬁed as either non-functioning
or functioning. Functioning NETs secrete various peptide hormones,
which act at distant sites and can result in a variety of clinical
syndromes. Pancreatic NETs can be benign or malignant, however
the majority of non-functioning tumors are malignant. Pancreatic
tumors in children rarely present with biliary obstruction, owing to
the expansive rather than inﬁltrative growth patterns of the common pediatric pancreatic neoplasms [3,4].
1. Case report
A 12 year-old female was referred to our center after presenting
to her local emergency department with a one-week history of
q This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/3.0/).
* Corresponding author. Western University, Children’s Hospital, Room B1-188,
800 Commissioners Road East, London, Ontario, Canada N6A 5W9. Tel.: þ1 519 685
8401; fax: þ1 519 685 8421.
E-mail addresses: andreana.butter@lhsc.on.ca, andreanabutter@gmail.com
(A. Bütter).

fatigue, pruritis, and acholic stools. She was visibly jaundiced. An
abdominal ultrasound at her local hospital suggested a mass within
the head of the pancreas. Her laboratory tests were: total bilirubin
136 umol/L, direct bilirubin 84.6 umol/L, alkaline phosphatase
543 U/L, alanine aminotransferase 172 U/L, and aspartate aminotransferase 75 U/L. Serum lipase was within normal limits.
Following these investigations, the patient was transferred to our
institution for further workup in hospital.
Magnetic resonance imaging (MRI) of the abdomen demonstrated extensive dilation throughout the intra and extrahepatic
biliary tree (Fig. 1). The common bile duct (CBD) measured 2.5 cm
with an abrupt transition at the pancreatic head. Within the
pancreatic head there was a 3 cm solid, smoothly marginated mass.
Computed tomography (CT) of the abdomen (Fig. 2) was also performed to better assess the surrounding vasculature. The lesion was
found to be in direct contact with the portal vein (PV) with a narrowed segment, suspicious for tumor inﬁltration. Both the superior
mesenteric artery (SMA) and superior mesenteric vein (SMV)
appeared to be uninvolved. There also appeared to be 5  3 mm
calculus within the CBD. Because of the biliary obstruction and
possible CBD stone, the patient underwent endoscopic retrograde
pancreaticochoangiogram (ERCP). This identiﬁed a tight stricture,
1 cm from the ampulla, for a distance of 5 mm. No stone was
identiﬁed and a plastic stent was placed for biliary drainage. ERCP
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Fig. 1. T2-weighted magnetic resonance imaging (MRI) demonstrating a mass in head
of pancreas (1) causing massive dilatation of the common bile duct (2).
Fig. 3. Posterior view of specimen: gastric antrum (1), pancreatic tumor (2), bile duct
(3), pancreatic neck margin (4), and duodenum (5).

was arranged prior to obtaining a tissue diagnosis because the
patient was highly symptomatic with pruritis.
Tumor markers were sent in an attempt to determine the etiology of this mass. Serum carbohydrate antigen 19-9 (CA19-9) was
mildly elevated at 38 U/ml. Serum carbohydrate antigen 125
(CA-125), b-human chorionic gonadotropin (b-HCG), alphafetoprotein (AFP) and Immunoglobulin 4 (IgG4) levels were within
normal limits. Furthermore, serum gastrin, insulin and chromogranin A were also non-elevated. Twenty-four hour urine collection
revealed normal levels of vanillylmandelic acid (VMA), homovanillic acid (HVA), and 5-hydroxyindole acetic acid (5-HIAA). A
bone marrow aspirate was also normal, making the diagnosis of
leukemia unlikely. CT chest was also normal.
This patient’s case was then reviewed in multi-disciplinary
tumor board rounds with radiology, pediatric medical oncology,
pathology, and pediatric surgery. A joint decision was made to
proceed with a surgical biopsy, as the group felt that percutaneous
biopsies were less likely to result in adequate tissue for pathologic
interpretation and had a theoretical potential for seeding the tumor through the needle tract. She was brought to the operating
room for laparoscopic biopsies of the pancreatic head. Tissue
samples sent to pathology for frozen sections revealed only
normal pancreatic tissue. As a result, interventional radiology was
consulted to perform ultrasound-guided, percutaneous biopsies
while the patient was under the same general anesthetic. These
specimens demonstrated a grade 2 NET (2 mitoses per 10 high
power ﬁelds, Ki-67 index 12%). Unfortunately, the patient bled
post-biopsy and underwent angiographic embolization of

Fig. 2. Coronal slice from computed tomography (CT) scan of the abdomen: pancreatic
mass (1), portal vein (2), and dilated common bile duct (3).

branches of the pancreaticoduodenal artery. She tolerated this
well and eventually recovered.
An octreotide scintigraphic scan was then performed. This
revealed no signiﬁcant octreotide uptake within the known
pancreatic tumor, and no evidence of octreotide-positive metastatic
disease. Although not available in our center, but commonly utilized
in Europe, a 68Ga DOTATOC/68Ga DOTATATE PET scan would have
been a good alternative imaging test for preoperative evaluation. If
positive, this would have provided an imaging modality for
postoperative surveillance.
The patient was then reviewed in multi-disciplinary neuroendocrine tumor board rounds. In conjunction with our adult
hepatopancreaticobiliary surgeons, a decision was made to take
the patient to the operating room for a pancreaticoduodenectomy
(Whipple’s procedure) with a plan for possible PV resection. The
mass was visible in the pancreatic head, with ﬁrm nodes along the
uncinate margin. The nodal tissue along the hepatic artery and
posterior to the SMA was cleared and sent with the specimen. She
underwent a standard pancreaticoduodenectomy with an end-toside pancreaticojejunostomy, end-to-side hepaticojejunostomy,
and a loop gastrojejunostomy. A frozen section of the pancreatic
resection margin was sent to pathology before reconstruction,
which was negative for malignancy (Fig. 3). A short segment
(5 mm) of the PV was resected, due to signiﬁcant tumor adherence, and reconstructed using an end-to-end anastomosis (Fig. 4).
Total clamp time was 25 min. We elected to perform a primary
anastamosis of the PV rather than a vein graft due to the short
segment of resection, and the fact that it came together under no
tension. On ﬁnal pathology the PV was not inﬁltrated with tumor
and therefore the dense adherence was likely desmoplastic
reaction.
Final pathology demonstrated a T3N1M0 grade 2 (World Health
Organization Classiﬁcation) pancreatic NET with negative resection
margins. The tumor extended beyond the pancreas but did not
involve the celiac axis or SMA. Lymphovascular and perineural invasion were present. The Ki-67 index ranged from 3% to 20%. Five
out of nineteen lymph nodes were positive. She was again presented at our neuroendocrine tumor board. Given her complete
resection and the non-functionality of her tumor, no further
treatment was recommended. Adjuvant treatment of completely
resected (R0) pancreatic neuroendocrine tumors is somewhat
controversial, however after consultation with international experts and a through literature review, it was felt that the potential
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Fig. 4. Following removal of specimen: probe marking pancreatic duct (1), superior
mesenteric vein (2), and liver (3).

for toxicity in a young patient outweighed the questionable beneﬁt.
She will require pancreatic imaging every 3 months for the next 2
years and continued long-term follow-up. Genetic screening for
multiple endocrine neoplasia (MEN) and Von Hippel-Lindau (VHL)
syndromes has been undertaken given the rarity of pancreatic NET
and the implication on further screening.
The patient recovered uneventfully post-operatively. An
asymptomatic portal vein thrombus was demonstrated on
screening ultrasound and anti-coagulation was initiated. The etiology of this thrombus was felt to be secondary to endothelial
trauma from the reconstruction. At 6 weeks, the PV thrombosis had
completely resolved and anti-coagulation was discontinued. At her
3-month follow-up, she continued to do well with no signs of
recurrence on CT.
2. Discussion
Pancreatic tumors in children and adolescents are exceedingly
rare, and as such, there is a paucity of data on this topic. The literature
consists predominately of single institution case series carried out
over long time periods. Investigators from Memorial Sloan-Kettering
published a retrospective review of pediatric patients less than 21
years of age with malignant pancreatic tumors [3]. Patients with
MEN were excluded. They identiﬁed sixteen patients with pancreatic neoplasms over a 35-year time period. Solid pseudopapillary
tumors (SPT) were the most common pathological subtype, followed
closely by pancreatoblastomas (PB) [3]. Only 2 patients (12.5%) had
NETs: one was non-functional and the other was a malignant vasoactive intestinal peptide-secreting neuroendocrine tumor (VIPoma).
The largest case series published to date is from the Hospital for Sick
Children in Toronto, Canada. In this series 27 patients were identiﬁed
over a 34-year time period (1986e2010). Again, SPT was the most
common pathology (66.7%) followed by NET (22.2%). There were no
patients with PB in this series [5]. Half of NETs were functional (2
insulinomas, 1 glucogonoma) [5]. Preoperative biopsy was only
performed in a third of cases, however 80% of biopsies were diagnostic, and no morbidity was attributed to biopsy [5].
Other reports of pancreatic masses in children include: ductal
adenocarcinoma, acinar cell carcinoma, peripheral neuroectodermal tumor (PNET), rhabdomyosarcoma, ﬁbrosarcoma,
Ewing sarcoma, lymphoma and teratoma [3,5e7]. Ductal adenocarcinoma, the predominant tumor type in adults, is exceptionally
rare in the pediatric population. Non-neoplastic etiologies such as
autoimmune pancreatitis are also possible [4].

415

The majority of children or adolescents with pancreatic neoplasms present with abdominal pain, emesis or a palpable mass
[3,5]. Biliary obstruction is rare [3,4]. Unlike ductal adenocarcinoma, the majority of pediatric pancreatic tumors exhibit an
expansive growth pattern, and push nearby structures aside rather
than invading them. Furthermore, they do not have a predilection
for the pancreatic head, with only 38% found in this location in the
series from Memorial Sloan-Kettering [3]. In particular, NET have a
predilection for the pancreatic tail [5].
Complete surgical resection is the mainstay of treatment for
malignant tumors of the pancreas in children. Due to the infrequent
nature of these neoplasms and the histologic heterogeneity, the role
of chemotherapy and radiotherapy is anecdotal, and their role in
the adjuvant setting has yet to be clearly established [1,3]. In
contrast to the adult population, most children have resectable
disease at the time of presentation [3]. In a single-center retrospective review of pediatric patients undergoing pancreatic resection for mass lesions, 19 of 20 had an R0 resection [1]. There was no
peri-operative mortality, but 25% of patients experienced perioperative morbidity. The most common complication was a
pancreatic leak (15%) [1]. Median follow-up was 49.5 months and
no patients experienced recurrence. Four patients (20%) developed
pancreatic exocrine deﬁciency and one (5%) became diabetic
postoperatively. These results are similar to those reported from
Memorial Sloan-Kettering and MD Anderson [1,3,8].
Extra-appendiceal NETs are rare in children, with an incidence of
0.5 per million [9]. Approximately 25% of pediatric pancreatic
neoplasms are NETs [1,2,5]. The WHO grading system for NET depends entirely on histopathologic criteria, including proliferation
index (Ki-67 index), mitotic count, and the presence or absence of
tumor necrosis. The most common symptom at diagnosis is
abdominal pain (85%) and weight loss (46%), while jaundice is rare
[9]. The majority of pancreatic NETs in children and adolescents are
non-functioning tumors [9]. In some case series, up to 50% of
children had metastatic disease at presentation, and localized disease is less common in pancreatic NET than with other sites of
extra-appendiceal NET [8,9]. These tumors may be associated with
genetic syndromes such as MEN, Von Hippel-Lindau syndrome,
Neuroﬁbromatosis type 1, or tuberous sclerosis [5,8]. It is unknown
whether high-grade tumors (WHO grade 2 or 3) are more common
in the pediatric population.
The gold standard of treatment for extra-appendiceal NET is
complete surgical resection. If complete surgical resection is not
achieved, these tumors have a tendency to recur locally or metastasize [8]. NETs respond poorly to chemotherapy. Over-expression
of the somatostatin receptor is common in these tumors, so peptide
receptor radionucleotide therapy is possible [8]. There is no standardized chemotherapy regimen in children, but in adults, both
streptozotocin and ﬂuorouracil are ﬁrst-line treatments for stage III
or greater [9]. Chemotherapy may have many adverse effects on the
developing child, including failure to thrive, infertility and a signiﬁcant risk of secondary malignancy. The case series from MD
Anderson estimated a 3-year overall survival rate for children with
pancreatic NET of 75% (95% CI 13%e96%) [8].
3. Conclusions
Pancreatic tumors in children and adolescents are rare.
Pancreatic NETs only represent 25% of these neoplasms. Unlike
adults, these tumors rarely present with biliary obstruction and
have a good prognosis if complete surgical resection can be achieved. The preoperative work-up of a child with a pancreatic mass
should include IgG4 levels as well as tumor markers (AFP, CA19-9,
chromogranin A). Core biopsies should be strongly considered to
avoid unnecessary surgical management in patients with
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autoimmune pancreatitis or lymphoma. Overall survival is signiﬁcantly better among children with localized disease compared to
those with distant spread.
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